Call for Poster Abstracts

The 2nd Point of Care Testing Advances Conference committee invites you to submit a poster abstract for inclusion in the scientific agenda.

Abstract Categories:

  • POCT and coagulation testing
  • POCT connectivity
  • POCT accreditation
  • POCT innovation

To submit, please read the guidelines below and complete the 2nd POCT Abstract Submission Form.

Deadline for Submission: October 14, 2018


The limit for the abstract is 250 words, exclusive of the abstract title.

An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. It is encouraged that the title is set so as to attract the audience and to hint to the conclusion of the investigation.


  1. The introduction of the abstract should include a very brief background 1-2 statements followed by the objectives of the investigation
  2. The methods section should briefly describe how the research was conducted
  3. In the results section it is expected that authors present data that support their conclusion
  4. Use generic names. Use trade names only when necessary.
  5. Avoid beginning sentences with numerals.
  6. Standard abbreviations may be used without definition. Nonstandard abbreviations should be placed in parentheses after the first use of the word or phrase abbreviated.
  7. No references, credits or grant support should be included in the abstract.
  8. No identifying information about patients participating in a study or trial should be used.
  9. Proofread abstracts carefully to avoid errors before submission. No corrections will be allowed or made once the abstract has been submitted.

Writing an Abstract

Title: Make the title dynamic and conclusive, rather than descriptive

Structure: A well-written abstract typically has the following identified sections: Purpose, Methods, Results and Conclusions.

Category: Check submission category carefully to assure proper consideration.

Length: Maximum length is 250 words, including tables and graphs.


Co-Author Approval

The submitting author must verify that all co-authors have read and approved the abstract submission.

Disclosure Form

A disclosure form identifying commercial relationships for all co-authors must be completed online by the submitting author, if their abstract has been accepted for publication. The submitting author signs and verifies disclosure on behalf of all co-authors. Disclosure information for accepted abstracts will be made available to the meeting attendees.